<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors></authors><secondary-authors><author><style face="normal" font="default" size="100%">Maggioni, Aldo P.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Rosuvastatin Only Minimally Effective in Reducing AF in Patients with HF</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2009</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2009-11-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">20-21</style></pages><abstract><style  face="normal" font="default" size="100%">This article data from a post hoc analysis of the Effect of rosuvastatin in patients with chronic heart failure [GISSI-HF; NCT00336336] study, showing only modest evidence of a reduction in atrial fibrillation (AF) in heart failure (HF) patients who were treated with rosuvastatin. The aim of the subanalysis was to assess the effect of n-3 PUFA and rosuvastatin compared with placebo in patients with chronic HF who were not in AF at study entry.</style></abstract><number><style face="normal" font="default" size="100%">4</style></number><volume><style face="normal" font="default" size="100%">9</style></volume></record></records></xml>